Adial Pharmaceuticals, Inc.
ADIL
$0.6748
-$0.0152-2.20%
| Weiss Ratings | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.88 | |||
| Price History | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.96% | |||
| 30-Day Total Return | -12.25% | |||
| 60-Day Total Return | -37.45% | |||
| 90-Day Total Return | -33.84% | |||
| Year to Date Total Return | -36.37% | |||
| 1-Year Total Return | -45.58% | |||
| 2-Year Total Return | -91.99% | |||
| 3-Year Total Return | -98.73% | |||
| 5-Year Total Return | -97.82% | |||
| 52-Week High % Change | -77.74% | |||
| 52-Week Low % Change | 12.38% | |||
| Price | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.10 | |||
| 52-Week Low Price | $0.61 | |||
| 52-Week Low Price (Date) | Mar 11, 2025 | |||
| 52-Week High Price (Date) | Apr 15, 2024 | |||
| Valuation | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.54M | |||
| Enterprise Value | 785.94K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.48 | |||
| Earnings Per Share Growth | -8.10% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.10 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.67 | |||
| Enterprise Value/EBITDA (TTM) | -0.09 | |||
| Enterprise Value/EBIT | -0.09 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.42M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (804) 487-8196 | |||
| Address | 4870 Sadler Road Glen Allen, VA 23060 | |||
| Website | www.adial.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -105.88% | |||
| Return on Equity | -- | |||
| Income Statement | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -8.28M | |||
| EBIT (TTM) | -8.28M | |||
| Net Income (TTM) | -13.20M | |||
| Net Income Avl. to Common (TTM) | -13.20M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -8.74% | |||
| EPS Diluted (TTM) | -3.48 | |||
| EPS Diluted Growth (Q YOY) | 60.75% | |||
| Balance Sheet | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.75M | |||
| Cash Per Share (Q) | $0.58 | |||
| Total Current Assets (Q) | 4.06M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.07M | |||
| Current Ratio (Q) | 4.159 | |||
| Book Value Per Share (Q) | $0.63 | |||
| Total Assets (Q) | 5.04M | |||
| Total Current Liabilities (Q) | 975.90K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 975.90K | |||
| Total Common Equity (Q) | 4.07M | |||
| Cash Flow | ADIL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 7.85M | |||
| Net Change in Cash (TTM) | 923.40K | |||
| Levered Free Cash Flow (TTM) | -3.99M | |||
| Cash from Operations (TTM) | -6.92M | |||
